Francesco Violi

Q: What Schools Are Affiliated With Francesco Violi

Francesco Violi is affiliated with the following schools: D'Annunzio University of Chieti–Pescara, University of Milan, University of Brescia, Sapienza University of Rome, University of Bologna

Francesco Violi's AcademicInfluence.com Rankings

Francesco Violi

Physics

#4528

World Rank

#6208

Historical Rank

physics Degrees

Download Badge

Physics

Francesco Violi's Degrees

Masters Physics University of Milan
Bachelors Physics University of Bologna

Why Is Francesco Violi Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Francesco Violi's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients (1994) (3667)
Antiplatelet treatment with ticlopidine in unstable angina. A controlled multicenter clinical trial. The Studio della Ticlopidina nell'Angina Instabile Group. (1990) (396)
Localization of distinct F2-isoprostanes in human atherosclerotic lesions. (1997) (357)
Hydrogen peroxide is involved in collagen-induced platelet activation. (1998) (305)
TYPE-III HYPERUPOPROTEINÆMIA (1977) (290)
The flavonoids quercetin and catechin synergistically inhibit platelet function by antagonizing the intracellular production of hydrogen peroxide. (2000) (290)
Insulin resistance, the metabolic syndrome, and nonalcoholic fatty liver disease. (2005) (285)
Chronic obstructive pulmonary disease is associated with an increase in urinary levels of isoprostane F2alpha-III, an index of oxidant stress. (1998) (277)
Effects of Anticoagulants in Patients With Cirrhosis and Portal Vein Thrombosis: A Systematic Review and Meta-analysis. (2017) (262)
Acute Impact of Tobacco vs Electronic Cigarette Smoking on Oxidative Stress and Vascular Function. (2016) (259)
Oxygen free radicals and platelet activation. (1997) (239)
Diabetes mellitus, hypercholesterolemia, and hypertension but not vascular disease per se are associated with persistent platelet activation in vivo. Evidence derived from the study of peripheral arterial disease. (1997) (232)
Local Amplification of Platelet Function by 8-Epi Prostaglandin F2α Is Not Mediated by Thromboxane Receptor Isoforms* (1996) (218)
Simvastatin inhibits the monocyte expression of proinflammatory cytokines in patients with hypercholesterolemia. (2000) (218)
Polyphenols synergistically inhibit oxidative stress in subjects given red and white wine. (2006) (195)
Hypercoagulation and Antithrombotic Treatment in Coronavirus 2019: A New Challenge (2020) (190)
Short-Term Treatment With Atorvastatin Reduces Platelet CD40 Ligand and Thrombin Generation in Hypercholesterolemic Patients (2005) (173)
Effects of resveratrol and other wine polyphenols on vascular function: an update. (2011) (169)
Circadian variation in the frequency of ischemic stroke. (1990) (168)
Patients with liver cirrhosis suffer from primary haemostatic defects? Fact or fiction? (2011) (162)
High plasma levels of von Willebrand factor as a marker of endothelial perturbation in cirrhosis: Relationship to endotoxemia (1996) (161)
Inhibition of platelet aggregation by aspirin progressively decreases in long-term treated patients. (2004) (160)
gp91phox-Dependent Expression of Platelet CD40 Ligand (2004) (158)
Resveratrol, at concentrations attainable with moderate wine consumption, stimulates human platelet nitric oxide production. (2008) (157)
Oxidative stress: New insights on the association of non-alcoholic fatty liver disease and atherosclerosis. (2015) (155)
Immediate Antioxidant and Antiplatelet Effect of Atorvastatin via Inhibition of Nox2 (2012) (149)
Platelet activation by superoxide anion and hydroxyl radicals intrinsically generated by platelets that had undergone anoxia and then reoxygenated. (1997) (148)
Association of Anticholinergic Burden with Cognitive and Functional Status in a Cohort of Hospitalized Elderly: Comparison of the Anticholinergic Cognitive Burden Scale and Anticholinergic Risk Scale (2013) (147)
Statins as Antithrombotic Drugs (2013) (145)
Cardiovascular Complications and Short-term Mortality Risk in Community-Acquired Pneumonia (2017) (144)
Anti-inflammatory and anti-atherogenic effects of cathechin, caffeic acid and trans-resveratrol in apolipoprotein E deficient mice. (2007) (144)
Atrial Fibrillation and Myocardial Infarction: A Systematic Review and Appraisal of Pathophysiologic Mechanisms (2016) (143)
Increased Liver Localization of Lipopolysaccharides in Human and Experimental NAFLD (2019) (139)
Conjunctivitis and COVID‐19: A meta‐analysis (2020) (138)
Platelet activation is associated with myocardial infarction in patients with pneumonia. (2014) (137)
Association between low-grade disseminated intravascular coagulation and endotoxemia in patients with liver cirrhosis. (1995) (135)
Moderate alcohol use and health: a consensus document. (2013) (135)
Cardiac tachyarrhythmias and patient values and preferences for their management: the European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisi (2015) (132)
Polyphenols enhance platelet nitric oxide by inhibiting protein kinase C‐dependent NADPH oxidase activation: effect on platelet recruitment (2006) (132)
Inherited Human gp91phox Deficiency Is Associated With Impaired Isoprostane Formation and Platelet Dysfunction (2011) (132)
IS ALBUMIN PREDICTOR OF MORTALITY IN COVID-19 ? (2020) (130)
Concepts and Controversies in Haemostasis and Thrombosis Associated with Liver Disease: Proceedings of the 7th International Coagulation in Liver Disease Conference (2018) (128)
Measurement of oxysterols and alpha-tocopherol in plasma and tissue samples as indices of oxidant stress status. (2003) (128)
Concepts and Controversies in Haemostasis and Thrombosis Associated with Liver Disease: Proceedings of the 7th International Coagulation in Liver Disease Conference (2018) (128)
Ticlopidine in the treatment of intermittent claudication: a 21-month double-blind trial. (1989) (126)
Iron-dependent human platelet activation and hydroxyl radical formation: involvement of protein kinase C. (1999) (125)
Oxidative-stress-mediated arterial dysfunction in patients with peripheral arterial disease. (2006) (124)
Enhanced lipid peroxidation in patients positive for antiphospholipid antibodies. (1997) (120)
Angioplasty increases coronary sinus F2-isoprostane formation: evidence for in vivo oxidative stress during PTCA. (2001) (120)
Picotamide, a combined inhibitor of thromboxane A2 synthase and receptor, reduces 2-year mortality in diabetics with peripheral arterial disease: the DAVID study. (2004) (119)
Hereditary Deficiency of gp91phox Is Associated With Enhanced Arterial Dilatation: Results of a Multicenter Study (2009) (119)
Oxidative stress and cardiovascular disease: new insights. (2018) (115)
Nitric oxide and its role in lipid peroxidation (1999) (108)
Relation of Cardiac Complications in the Early Phase of Community-Acquired Pneumonia to Long-Term Mortality and Cardiovascular Events. (2015) (108)
Hypercoagulability State in Patients with Chronic Obstructive Pulmonary Disease (1994) (104)
Nonalcoholic Fatty Liver Disease and Fibrosis Associated With Increased Risk of Cardiovascular Events in a Prospective Study. (2019) (104)
Enhanced lipid peroxidation in hepatic cirrhosis. (1998) (103)
Inhibition of tissue-factor-mediated thrombin generation by simvastatin. (2000) (103)
Hyperfibrinolysis increases the risk of gastrointestinal hemorrhage in patients with advanced cirrhosis (1992) (102)
Superoxide Anion and Hydroxyl Radical Release by Collagen-induced Platelet Aggregation - Role of Arachidonic Acid Metabolism (2000) (100)
Effect of Picotamide on the Clinical Progression of Peripheral Vascular Disease A Double‐Blind Placebo‐Controlled Study (1993) (99)
Chocolate, Lifestyle, and Health (2009) (99)
Adherence to Mediterranean Diet and Non-Alcoholic Fatty Liver Disease: Effect on Insulin Resistance (2017) (98)
Hyperfibrinolysis Resulting from Clotting Activation in Patients with Different Degrees of Cirrhosis (1993) (97)
Platelet oxidative stress and thrombosis. (2012) (97)
Nox2 activation in Covid-19 (2020) (96)
Acute Effects of Heat‐Not‐Burn, Electronic Vaping, and Traditional Tobacco Combustion Cigarettes: The Sapienza University of Rome‐Vascular Assessment of Proatherosclerotic Effects of Smoking (SUR‐VAPES) 2 Randomized Trial (2019) (96)
Carnitine inhibits arachidonic acid turnover, platelet function, and oxidative stress. (2003) (93)
Is Acetylsalicylic Acid a Safe and Potentially Useful Choice for Adult Patients with COVID-19 ? (2020) (91)
Oxidative stress mediated arterial dysfunction in patients with obstructive sleep apnoea and the effect of continuous positive airway pressure treatment (2012) (91)
Hyperfibrinolysis in liver disease. (2009) (90)
Role of hydroxyl radicals in the activation of human platelets. (1994) (90)
Atherothrombosis and Oxidative Stress: Mechanisms and Management in Elderly. (2017) (90)
Integrated Care Management of Patients With Atrial Fibrillation and Risk of Cardiovascular Events: The ABC (Atrial fibrillation Better Care) Pathway in the ATHERO-AF Study Cohort. (2019) (90)
LDL oxidation by platelets propagates platelet activation via an oxidative stress-mediated mechanism. (2014) (90)
Lower Mortality Rate in Elderly Patients With Community‐Onset Pneumonia on Treatment With Aspirin (2015) (89)
Low‐grade endotoxemia and platelet activation in cirrhosis (2017) (89)
Bleeding time in patients with cirrhosis: relation with degree of liver failure and clotting abnormalities. C.A.L.C. Group. Coagulation Abnormalities in Cirrhosis Study Group. (1994) (88)
Relation between risk factors and cardiovascular complications in patients with peripheral vascular disease. Results from the A.D.E.P. study. (1996) (88)
Gut‐Derived Serum Lipopolysaccharide is Associated With Enhanced Risk of Major Adverse Cardiovascular Events in Atrial Fibrillation: Effect of Adherence to Mediterranean Diet (2017) (85)
Extra Virgin Olive Oil and Cardiovascular Diseases: Benefits for Human Health. (2017) (84)
Tumor necrosis factor-α as trigger of platelet activation in patients with heart failure (2005) (84)
Atorvastatin Inhibits gp91phox Circulating Levels in Patients With Hypercholesterolemia (2010) (83)
Nonalcoholic Fatty Liver Disease Is Associated With Ventricular Arrhythmias in Patients With Type 2 Diabetes Referred for Clinically Indicated 24-Hour Holter Monitoring (2016) (83)
Radiolabeled native low-density lipoprotein injected into patients with carotid stenosis accumulates in macrophages of atherosclerotic plaque : effect of vitamin E supplementation. (2000) (82)
Ongoing Prothrombotic State in the Portal Circulation of Cirrhotic Patients (1997) (82)
Preparation and biodistribution of 99m technetium labelled oxidized LDL in man. (1996) (82)
Soluble CD40 Ligand Predicts Ischemic Stroke and Myocardial Infarction in Patients With Nonvalvular Atrial Fibrillation (2007) (82)
Extra virgin olive oil use is associated with improved post-prandial blood glucose and LDL cholesterol in healthy subjects (2015) (81)
Portal vein thrombosis relevance on liver cirrhosis: Italian Venous Thrombotic Events Registry (2016) (80)
A potent chain-breaking antioxidant activity of the cardiovascular drug dipyridamole. (1995) (79)
Free radical-mediated platelet activation by hemoglobin released from red blood cells. (1992) (78)
Enhanced thromboxane biosynthesis in patients with chronic obstructive pulmonary disease. The Chronic Obstructive Bronchitis and Haemostasis Study Group. (1997) (75)
Effect of coffee drinking on platelets: inhibition of aggregation and phenols incorporation. (2008) (75)
Ongoing prothrombotic state in patients with antiphospholipid antibodies: a role for increased lipid peroxidation. (1999) (74)
Enhanced TNFα and oxidative stress in patients with heart failure: effect of TNFα on platelet O2 - production (2003) (74)
99mTc-interleukin-2 scintigraphy for the in vivo imaging of vulnerable atherosclerotic plaques (2006) (74)
Platelet Count Does Not Predict Bleeding in Cirrhotic Patients: Results from the PRO-LIVER Study (2017) (73)
Oxidative stress-mediated arterial dysfunction in patients with metabolic syndrome: Effect of ascorbic acid. (2007) (72)
Hydrogen peroxide triggers activation of human platelets selectively exposed to nonaggregating concentrations of arachidonic acid and collagen. (1992) (71)
Obesity and hypercholesterolemia are associated with NOX2 generated oxidative stress and arterial dysfunction. (2012) (71)
CD40 ligand enhances monocyte tissue factor expression and thrombin generation via oxidative stress in patients with hypercholesterolemia. (2005) (71)
Localization of lipopolysaccharide from Escherichia Coli into human atherosclerotic plaque (2018) (71)
Simvastatin reduces monocyte-tissue-factor expression type IIa hypercholesterolaemia (1997) (71)
Portal vein thrombosis in liver cirrhosis (2008) (71)
Down's syndrome is associated with increased 8,12‐iso‐iPF2α‐VI levels: Evidence for enhanced lipid peroxidation in vivo (2000) (71)
Dark chocolate inhibits platelet isoprostanes via NOX2 down‐regulation in smokers (2012) (70)
Alpha-linolenic acid-rich wheat germ oil decreases oxidative stress and CD40 ligand in patients with mild hypercholesterolemia. (2006) (70)
Early decrease of oxidative stress by atorvastatin in hypercholesterolaemic patients: effect on circulating vitamin E. (2007) (69)
TYPE-III HYPERLIPOPROTEINAEMIA (1975) (69)
Coexistence of anti-phospholipid antibodies and endothelial perturbation in systemic lupus erythematosus patients with ongoing prothrombotic state. (1997) (69)
NOX2-generated oxidative stress is associated with severity of ultrasound liver steatosis in patients with non-alcoholic fatty liver disease (2014) (68)
Nutrition, Supplements, and Vitamins in Platelet Function and Bleeding (2010) (68)
Role of NADPH oxidase in atherosclerosis. (2009) (68)
Tissue plasminogen activator inhibitor in patients with systemic lupus erythematosus and thrombosis. (1990) (67)
Gut-derived endotoxin stimulates factor VIII secretion from endothelial cells. Implications for hypercoagulability in cirrhosis. (2017) (67)
Incidence of bleeding in patients with atrial fibrillation and advanced liver fibrosis on treatment with vitamin K or non-vitamin K antagonist oral anticoagulants. (2018) (65)
Metformin decreases platelet superoxide anion production in diabetic patients (2002) (64)
Extra virgin olive oil blunt post-prandial oxidative stress via NOX2 down-regulation. (2014) (64)
Persistent production of platelet thromboxane A2 in patients chronically treated with aspirin (2005) (64)
Oxidative Stress Is Associated With Arterial Dysfunction and Enhanced Intima-Media Thickness in Children With Hypercholesterolemia: The Potential Role of Nicotinamide-Adenine Dinucleotide Phosphate Oxidase (2008) (64)
Incidence of myocardial infarction and vascular death in elderly patients with atrial fibrillation taking anticoagulants: relation to atherosclerotic risk factors. (2015) (63)
Seronegative antiphospholipid syndrome: refining the value of “non-criteria” antibodies for diagnosis and clinical management (2020) (63)
Platelet NOX, a novel target for anti-thrombotic treatment (2014) (63)
Pneumonia, thrombosis and vascular disease (2014) (62)
Association between High Values of D-dimer and Tissue-plasminogen Activator Activity and First Gastrointestinal Bleeding in Cirrhotic Patients (1996) (61)
LDL are oxidatively modified by platelets via GP91phox and accumulate in human monocytes (2007) (61)
Individualizing Risk of Multidrug-Resistant Pathogens in Community-Onset Pneumonia (2015) (61)
Relation between lupus anticoagulant and splanchnic venous thrombosis in cirrhosis of the liver (1994) (61)
Oleuropein, a component of extra virgin olive oil, lowers postprandial glycaemia in healthy subjects (2018) (60)
ABC (Atrial fibrillation Better Care) Pathway and Healthcare Costs in Atrial Fibrillation: The ATHERO-AF Study. (2019) (60)
Inadequate anticoagulation by Vitamin K Antagonists is associated with Major Adverse Cardiovascular Events in patients with atrial fibrillation. (2015) (59)
NOX2-mediated arterial dysfunction in smokers: acute effect of dark chocolate (2011) (59)
Enhanced expression of monocyte tissue factor in patients with liver cirrhosis (1998) (59)
Prevalence of peripheral artery disease by abnormal ankle-brachial index in atrial fibrillation: implications for risk and therapy. (2013) (59)
Intravenous ascorbic acid infusion improves myocardial perfusion grade during elective percutaneous coronary intervention: relationship with oxidative stress markers. (2010) (59)
Bioavailability of Vitamin E as Function of Food Intake in Healthy Subjects: Effects on Plasma Peroxide–Scavenging Activity and Cholesterol-Oxidation Products (2001) (58)
Antioxidants and cardiovascular disease. (2005) (58)
NOX2 up-regulation is associated with artery dysfunction in patients with peripheral artery disease. (2013) (58)
Hemostatic balance in patients with liver cirrhosis: Report of a consensus conference. (2016) (58)
Reduced Lysosomal Acid Lipase Activity in Adult Patients With Non-alcoholic Fatty Liver Disease (2015) (58)
Vitamin E inhibits collagen-induced platelet activation by blunting hydrogen peroxide. (1999) (58)
Evaluation of D-dimer and factor VIII in cirrhotic patients with asymptomatic portal venous thrombosis. (2005) (58)
Imbalance between nitric oxide generation and oxidative stress in patients with peripheral arterial disease: effect of an antioxidant treatment. (2006) (56)
gp 91 phox-Dependent Expression of Platelet CD 40 Ligand (2004) (55)
Hypoalbuminemia, Coagulopathy and Vascular Disease in Covid-19. (2020) (55)
Oxidative stress‐mediated platelet CD40 ligand upregulation in patients with hypercholesterolemia: effect of atorvastatin (2006) (55)
Serum NOX2 and urinary isoprostanes predict vascular events in patients with atrial fibrillation (2014) (52)
Oxidative stress in patients affected by primary aldosteronism (2014) (51)
Localization of Distinct F 2 -Isoprostanes in Human Atherosclerotic Lesions (1997) (51)
Supplementation with vitamin E alone is associated with reduced myocardial infarction: a meta-analysis. (2015) (51)
Dark Chocolate Acutely Improves Walking Autonomy in Patients With Peripheral Artery Disease (2014) (51)
Polymorphonuclear leukocyte-derived O2-reactive species activate primed platelets in human whole blood. (1993) (51)
Hyperhomocysteinaemia and poor vitamin B status in chronic obstructive pulmonary disease. (2009) (51)
NADPH Oxidase-2 and Atherothrombosis: Insight From Chronic Granulomatous Disease. (2017) (51)
Does Mediterranean Diet Reduce Cardiovascular Events and Oxidative Stress in Atrial Fibrillation? (2015) (49)
Relationship of PCSK9 and Urinary Thromboxane Excretion to Cardiovascular Events in Patients With Atrial Fibrillation. (2017) (49)
Low-grade endotoxaemia enhances artery thrombus growth via Toll-like receptor 4: implication for myocardial infarction. (2020) (49)
Increased rate of thrombin generation in hepatitis C virus cirrhotic patients. Relationship to venous thrombosis. (1995) (49)
Obstructive sleep apnoea syndrome and the metabolic syndrome in an internal medicine setting. (2010) (49)
Weight loss is associated with improved endothelial dysfunction via NOX2-generated oxidative stress down-regulation in patients with the metabolic syndrome (2012) (49)
Lipopolysaccharide as trigger of platelet aggregation via eicosanoid over-production (2017) (48)
Endothelial dysfunction and oxidative stress in children with sleep disordered breathing: role of NADPH oxidase. (2015) (47)
Should antioxidant status be considered in interventional trials with antioxidants? (2004) (46)
Reduced Atherosclerotic Burden in Subjects With Genetically Determined Low Oxidative Stress (2013) (46)
Increased Superoxide Anion Production by Platelets in Hypercholesterolemic Patients (2002) (46)
Protection of low density lipoprotein oxidation at chemical and cellular level by the antioxidant drug dipyridamole (1996) (46)
NADPH oxidase‐mediated platelet isoprostane over‐production in cirrhotic patients: implication for platelet activation (2011) (45)
Statins and Major Adverse Limb Events in Patients with Peripheral Artery Disease: A Systematic Review and Meta-Analysis (2020) (45)
Antioxidants for prevention of atrial fibrillation: a potentially useful future therapeutic approach? A review of the literature and meta-analysis. (2014) (45)
Serum Albumin Is Inversely Associated With Portal Vein Thrombosis in Cirrhosis (2019) (45)
Antioxidant and antiplatelet activity by polyphenol-rich nutrients: focus on extra virgin olive oil and cocoa. (2017) (45)
Aging‐Related Decline of Glutathione Peroxidase 3 and Risk of Cardiovascular Events in Patients With Atrial Fibrillation (2016) (45)
Extra virgin olive oil improves post-prandial glycemic and lipid profile in patients with impaired fasting glucose. (2017) (45)
Enhanced soluble CD40L in patients with the metabolic syndrome: relationship with in vivo thrombin generation (2006) (44)
Hereditary Deficiency of gp91 phox Is Associated With Enhanced Arterial Dilatation Results of a Multicenter Study (2009) (44)
Platelet Isoprostane Overproduction in Diabetic Patients Treated With Aspirin (2012) (44)
Italian intersociety consensus on DOAC use in internal medicine (2017) (44)
Vitamin C inhibits platelet expression of CD40 ligand. (2005) (43)
Bleeding and thrombosis in cirrhotic patients: what really matters? (2012) (43)
PNPLA3 variant and portal/periportal histological pattern in patients with biopsy-proven non-alcoholic fatty liver disease: a possible role for oxidative stress (2017) (43)
Tumor necrosis factor-alpha as trigger of platelet activation in patients with heart failure. (2005) (43)
Vitamin E reduces monocyte tissue factor expression in cirrhotic patients. (1999) (43)
Under-prescription of statins in patients with non-alcoholic fatty liver disease. (2017) (43)
Low-grade endotoxemia, gut permeability and platelet activation in community-acquired pneumonia. (2016) (43)
Cardiovascular risk stratification in patients with non-valvular atrial fibrillation: the 2MACE score (2016) (43)
Digoxin treatment is associated with increased total and cardiovascular mortality in anticoagulated patients with atrial fibrillation. (2015) (42)
Weight loss by multidisciplinary intervention improves endothelial and sexual function in obese fertile women. (2013) (42)
Clotting Activation and Hyperfibrinolysis in Cirrhosis: Implication for Bleeding and Thrombosis (2013) (42)
Impact of new oral anticoagulants on gastrointestinal bleeding in atrial fibrillation: A meta-analysis of interventional trials. (2015) (41)
Vitamin E Serum Levels and Bleeding Risk in Patients Receiving Oral Anticoagulant Therapy: a Retrospective Cohort Study (2013) (41)
Underuse of oral anticoagulants in patients with nonvalvular atrial fibrillation in Italy (2007) (41)
Platelet and leukocyte ROS production and lipoperoxidation are associated with high platelet reactivity in Non-ST elevation myocardial infarction (NSTEMI) patients on dual antiplatelet treatment. (2013) (40)
Bleeding time does not predict gastrointestinal bleeding in patients with cirrhosis. The CALC Group. Coagulation Abnormalities in Liver Cirrhosis. (1996) (40)
Prognostic value of clotting and fibrinolytic systems in a follow-up of 165 liver cirrhotic patients. CALC Group. (1995) (40)
Enhanced platelet release of superoxide anion in systemic hypertension: role of AT1 receptors (2004) (40)
The coagulopathy of chronic liver disease: is there a causal relationship with bleeding? Yes. (2010) (39)
Nox2 up-regulation is associated with an enhanced risk of atrial fibrillation in patients with pneumonia (2015) (39)
Rosuvastatin reduces platelet recruitment by inhibiting NADPH oxidase activation. (2012) (38)
Lupus Anticoagulant and the Fibrinolytic System in Young Patients With Stroke (1993) (38)
Nox2 is determinant for ischemia-induced oxidative stress and arterial vasodilatation: a pilot study in patients with hereditary Nox2 deficiency. (2006) (37)
Fluorescence quenching of dipyridamole associated to peroxyl radical scavenging: a versatile probe to measure the chain breaking antioxidant activity of biomolecules. (2000) (37)
Early increase of oxidative stress and soluble CD40L in children with hypercholesterolemia. (2007) (36)
Myocardial infarction and atrial fibrillation: different impact of anti-IIa vs anti-Xa new oral anticoagulants: a meta-analysis of the interventional trials. (2015) (36)
Prognostic role of plasma von Willebrand factor and soluble E‐selectin levels for future cardiovascular events in a ‘real‐world’ community cohort of patients with atrial fibrillation (2013) (34)
Protection of low density lipoprotein oxidation by the antioxidant agent IRFI005, a new synthetic hydrophilic vitamin E analogue. (1999) (34)
Anoxia-Reoxygenation Enhances Platelet Thromboxane A2 Production via Reactive Oxygen Species–Generated NOX2: Effect in Patients Undergoing Elective Percutaneous Coronary Intervention (2011) (34)
Hydrogen peroxide as trigger of platelet aggregation. (1991) (34)
Assessment of risk factors for candidemia in non-neutropenic patients hospitalized in Internal Medicine wards: A multicenter study. (2017) (33)
Enhanced monocyte expression of tissue factor by oxidative stress in patients with antiphospholipid antibodies: effect of antioxidant treatment (2003) (33)
Ankle-Brachial Index and cardiovascular events in atrial fibrillation (2016) (33)
Nox-2 up-regulation and platelet activation: Novel insights. (2015) (33)
Remnant Lipoprotein Cholesterol and Cardiovascular and Cerebrovascular Events in Patients with Non-Alcoholic Fatty Liver Disease (2018) (33)
Effects of dark chocolate on endothelial function in patients with non-alcoholic steatohepatitis. (2017) (33)
Validation of an LC-MS/MS method for the simultaneous quantification of dabigatran, rivaroxaban and apixaban in human plasma. (2016) (33)
Pneumonia in frail older patients: an up to date (2012) (33)
Interaction Between Dietary Vitamin K Intake and Anticoagulation by Vitamin K Antagonists: Is It Really True? (2016) (33)
Different Degrees of NADPH Oxidase 2 Regulation and In Vivo Platelet Activation: Lesson From Chronic Granulomatous Disease (2014) (32)
Peripheral artery disease and atrial fibrillation: a potentially dangerous combination (2012) (32)
Antioxidant and antiplatelet effects of atorvastatin by Nox2 inhibition. (2014) (32)
Red and white wine differently affect collagen-induced platelet aggregation (2002) (32)
Different behaviour of NOX2 activation in patients with paroxysmal/persistent or permanent atrial fibrillation (2012) (31)
Upstream therapy with statin and recurrence of atrial fibrillation after electrical cardioversion. Review of the literature and meta-analysis (2012) (31)
Prekallikrein and factor VII as prognostic indexes of liver failure. (1986) (31)
Quantifying the Effects of Prior Acetyl-Salicylic Acid on Sepsis-Related Deaths: An Individual Patient Data Meta-Analysis Using Propensity Matching* (2017) (31)
Effects of dark chocolate on NOX‐2‐generated oxidative stress in patients with non‐alcoholic steatohepatitis (2016) (31)
Reaction of dipyridamole with the hydroxyl radical (1992) (31)
Influence of ascorbic acid on platelet aggregation in vitro and in vivo. (1982) (31)
Lupus anticoagulant and increased thrombin generation in patients with systemic lupus erythematosus. (1994) (31)
Relationship between carotid intima-media thickness and non valvular atrial fibrillation type. (2015) (30)
Tumour necrosis factor alpha upregulates platelet CD40L in patients with heart failure. (2008) (30)
Does NADPH oxidase deficiency cause artery dilatation in humans? (2013) (30)
Leukocyte response in patients suffering from acute stroke. (1988) (30)
Superoxide dismutase triggers activation of "primed" platelets. (1991) (30)
Corticosteroid Use and Incident Myocardial Infarction in Adults Hospitalized for Community‐acquired Pneumonia (2019) (30)
Eltrombopag before procedures in patients with cirrhosis and thrombocytopenia. (2012) (30)
Prevalence of lupus anticoagulant in patients with cirrhosis: relationship with beta-2-glycoprotein I plasma levels. (1994) (30)
Inhibition of cyclooxygenase-independent platelet aggregation by low vitamin E concentration. (1990) (30)
Improvement of Walking Distance by Defibrotide in Patients with Intermittent Claudication (2000) (30)
Platelet hyperfunction in patients with chronic airways obstruction. (1985) (30)
Effect of l‐carnitine on oxidative stress and platelet activation after major surgery (2011) (29)
Anticoagulant therapy in patients with liver cirrhosis and portal vein thrombosis: insights for the clinician (2018) (29)
Epicatechin and Catechin Modulate Endothelial Activation Induced by Platelets of Patients with Peripheral Artery Disease (2014) (29)
MRC/BHF Heart Protection Study (2002) (28)
Mediterranean diet reduces thromboxane A2 production in atrial fibrillation patients. (2015) (28)
Oxidative Stress and Gut-Derived Lipopolysaccharides in Neurodegenerative Disease: Role of NOX2 (2020) (28)
Acute bacterial skin and skin structure infections in internal medicine wards: old and new drugs (2016) (28)
New Insights into the Steen Solution Properties: Breakthrough in Antioxidant Effects via NOX2 Downregulation (2014) (28)
Is NOX2 upregulation implicated in myocardial injury in patients with pneumonia? (2014) (28)
Vitamin E for the Treatment of Cardiovascular Disease: Is There a Future? (2004) (28)
Indobufen inhibits tissue factor in human monocytes through a thromboxane-mediated mechanism. (2006) (27)
Increased Thromboxane Metabolites Excretion in Liver Cirrhosis (1998) (27)
Role of portal venous platelet activation in patients with decompensated cirrhosis and TIPS (2019) (27)
Immunoglobulin G (IgG) anticardiolipin antibodies and recurrent cardiovascular events. A systematic review and Bayesian meta-regression analysis. (2019) (27)
C242T Polymorphism of NADPH Oxidase p22phox and Recurrence of Cardiovascular Events in Coronary Artery Disease (2008) (27)
COVID-19 and cardiovascular injury: A role for oxidative stress and antioxidant treatment? (2020) (27)
Albumin Supplementation Dampens Hypercoagulability in COVID-19: A Preliminary Report (2020) (27)
Mechanisms And Management Of Thrombo-Embolism In Atrial Fibrillation. (2014) (27)
Cirrhosis as a risk factor for venous thrombosis (2016) (26)
Low‐grade endotoxemia and clotting activation in the early phase of pneumonia (2016) (26)
Frequency of Left Ventricular Hypertrophy in Non-Valvular Atrial Fibrillation. (2015) (26)
Dilute aPTT Prolongation by Antiphospholipid Antibodies in Patients with Liver Cirrhosis (1990) (26)
Improvement of some blood coagulation factors in cirrhotic patients treated with low doses of heparin. (2009) (26)
Methods for detecting lupus anticoagulants and their relation to thrombosis and miscarriage in patients with systemic lupus erythematosus. (1992) (26)
Clinical Application of NOX Activity and Other Oxidative Biomarkers in Cardiovascular Disease: A Critical Review. (2015) (26)
1-year survey of patients with advanced liver cirrhosis. Prognostic value of clinical and laboratory indexes identified by the Cox regression model. (1992) (26)
Vitamin E potentiates the antiplatelet activity of aspirin in collagen-stimulated platelets. (2002) (26)
Medication prescription and adherence disparities in non valvular atrial fibrillation patients: an Italian portrait from the ARAPACIS study (2014) (26)
Dipyridamole: a drug with unrecognized antioxidant activity. (2015) (25)
Urinary 11-dehydro-thromboxane B2 is associated with cardiovascular events and mortality in patients with atrial fibrillation. (2015) (25)
The risk of myocardial infarction in patients with atrial fibrillation: an unresolved issue (2010) (25)
Comparison of efficacy of antiplatelet treatments for patients with claudication (2010) (25)
NADPH Oxidase Deficiency: A Multisystem Approach (2017) (25)
A review of picotamide in the reduction of cardiovascular events in diabetic patients (2007) (25)
Identification and management of invasive mycoses in internal medicine: a road-map for physicians (2014) (25)
Relation of nonalcoholic fatty liver disease and Framingham Risk Score to flow-mediated dilation in patients with cardiometabolic risk factors. (2015) (24)
Anticoagulant activity of anticardiolipin antibodies. (1986) (24)
Evidence for Anticoagulant Activity and β2-GPI Accumulation in Late Endosomes of Endothelial Cells Induced by Anti-LBPA Antibodies (2002) (24)
Hospitalization for Pneumonia is Associated With Decreased 1-Year Survival in Patients With Type 2 Diabetes (2016) (24)
Similar Reduction of Cholesterol-Adjusted Vitamin E Serum Levels in Simple Steatosis and Non-Alcoholic Steatohepatitis (2015) (24)
Von Willebrand and Factor VIII Portosystemic Circulation Gradient in Cirrhosis: Implications for Portal Vein Thrombosis (2020) (24)
Multiple anti‐atherosclerotic treatments impair aspirin compliance: effects on aspirin resistance (2008) (24)
Clotting abnormalities in chronic liver disease. (1992) (24)
Prevalence of hyperfibrinolysis in patients with liver cirrhosis (1993) (24)
Thrombopoietin receptor agonists and risk of portal vein thrombosis in patients with liver disease and thrombocytopenia: A meta-analysis. (2019) (23)
Mechanism of reaction of a suggested superoxide-dismutase mimic, Fe(II)-N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine. (1992) (23)
Prognostic value of clotting and fibrinolytic systems in a follow‐up of 165 liver cirrhotic patients (1995) (23)
Low-Grade Endotoxemia and Thrombosis in COVID-19 (2021) (23)
Incidence and Recurrence of Portal Vein Thrombosis in Cirrhotic Patients (2019) (23)
Aspirin for primary prevention in diabetes mellitus: from the calculation of cardiovascular risk and risk/benefit profile to personalised treatment (2015) (23)
Non-alcoholic fatty liver disease, metabolic syndrome and patatin-like phospholipase domain-containing protein3 gene variants. (2014) (23)
Relationship Between Platelet and Urinary 8‐Iso‐PGF2α Levels in Subjects With Different Degrees of NOX2 Regulation (2013) (23)
Myeloperoxidase overexpression in children with hypercholesterolemia. (2009) (23)
Atorvastatin inhibits oxidative stress via adiponectin-mediated NADPH oxidase down-regulation in hypercholesterolemic patients. (2010) (22)
The association between hyperhomocysteinemia and ischemic stroke in patients with non-valvular atrial fibrillation. (2005) (22)
Poor Adherence to Mediterranean Diet and Serum Lipopolysaccharide Are Associated with Oxidative Stress in Patients with Non-Alcoholic Fatty Liver Disease (2020) (22)
The effects of gliclazide on platelet function in patients with diabetes mellitus. (1982) (22)
Gut-derived low-grade endotoxaemia, atherothrombosis and cardiovascular disease (2022) (22)
New oral anticoagulants for the treatment of acute venous thromboembolism: are they safer than vitamin K antagonists? A meta-analysis of the interventional trials (2015) (22)
Picotamide, a combined inhibitor of thromboxane A2 synthase and receptor, reduces 2-year mortality in diabetics with peripheral arterial disease: The DAVID study (2005) (22)
Flow-mediated dilation is associated with cardiovascular events in non-valvular atrial fibrillation patients. (2015) (22)
PCSK9 Regulates Nox2-Mediated Platelet Activation via CD36 Receptor in Patients with Atrial Fibrillation (2020) (22)
Inhibition of tissue plasminogen activator inhibitor by defibrotide in atherosclerotic patients. (1989) (21)
Vitamin E supplementation (2001) (21)
Nutrition, Thrombosis, and Cardiovascular Disease (2020) (21)
The hyperfibrinolytic state of liver cirrhosis: possible pathogenetic role of ascites. (1993) (21)
Anti Xa oral anticoagulants inhibit in vivo platelet activation by modulating glycoprotein VI shedding. (2016) (21)
Ascorbic acid infusion blunts CD40L upregulation in patients undergoing coronary stent. (2011) (21)
Total Adiponectin Is Inversely Associated with Platelet Activation and CHA2DS2-VASc Score in Anticoagulated Patients with Atrial Fibrillation (2014) (21)
Low-grade endotoxemia, gut permeability and platelet activation in patients with impaired fasting glucose. (2017) (21)
Severe reduction of blood lysosomal acid lipase activity in cryptogenic cirrhosis: A nationwide multicentre cohort study. (2017) (20)
Statins enhance circulating vitamin E. (2008) (20)
Sex related differences in patients with acute venous thromboembolism treated with new oral anticoagulants. A meta-analysis of the interventional trials. (2016) (20)
Gut-derived lipopolysaccharides increase post-prandial oxidative stress via Nox2 activation in patients with impaired fasting glucose tolerance: effect of extra-virgin olive oil (2019) (20)
Thromboembolism or atherothromboembolism in atrial fibrillation? (2012) (20)
Association between prolonged bleeding time and gastrointestinal hemorrhage in 102 patients with liver cirrhosis: results of a retrospective study. (1994) (20)
How to select patient candidates for antioxidant treatment? (2002) (20)
Carotid plaque detection improves the predictive value of CHA2DS2-VASc score in patients with non-valvular atrial fibrillation: The ARAPACIS Study. (2017) (20)
Are nutraceuticals the modern panacea? From myth to science (2017) (20)
HIV-1 induces in vivo platelet activation by enhancing platelet NOX2 activity. (2015) (20)
Relationship between low Ankle-Brachial Index and rapid renal function decline in patients with atrial fibrillation: a prospective multicentre cohort study (2015) (19)
Relationship of peripheral and coronary artery disease to cardiovascular events in patients with atrial fibrillation. (2017) (19)
Patients with microvascular obstruction after primary percutaneous coronary intervention show a gp91phox (NOX2) mediated persistent oxidative stress after reperfusion (2013) (19)
Synergism among flavonoids in inhibiting platelet aggregation and H2O2 production. (2002) (19)
Low serum albumin levels and in-hospital outcomes in patients with ST segment elevation myocardial infarction. (2021) (19)
Temporal trends of time in therapeutic range and incidence of cardiovascular events in patients with non-valvular atrial fibrillation. (2018) (19)
Influence of hydroxyl radical scavengers on platelet function. (1988) (19)
Antiplatelet therapy in peripheral artery disease. (2012) (19)
Real-world safety and efficacy of direct oral anticoagulants in atrial fibrillation: a network metanalysis on 605,771 patients. (2021) (19)
Septic shock from community-onset pneumonia: is there a role for aspirin plus macrolides combination? (2016) (19)
Does Lysosomial Acid Lipase Reduction Play a Role in Adult Non-Alcoholic Fatty Liver Disease? (2015) (19)
Reduced lysosomal acid lipase activity: A new marker of liver disease severity across the clinical continuum of non-alcoholic fatty liver disease? (2019) (19)
Does Nox2 Overactivate in Children with Nonalcoholic Fatty Liver Disease? (2019) (18)
NADPH Oxidase-2 and AtherothrombosisHighlights (2017) (18)
Soluble CD154 plasma levels in patients with systemic lupus erythematosus: modulation by antiphospholipid antibodies. (2004) (18)
Thrombosis in the antiphospholipid-antibody syndrome. (1995) (18)
Involvement of Phospholipase A(2) in H(2)O(2)-dependent Platelet Activation. (1992) (18)
Apolipoproteins A-I, A-II and B in chronic active hepatitis and in liver cirrhotic patients. (1984) (18)
Increased plasminogen activator inhibitor antigen levels in diabetic patients with stable angina (1991) (18)
Vitamin E, Atherosclerosis and Thrombosis (2001) (18)
Low-density lipoprotein oxidation. (2001) (18)
Collagen type IV remodelling gender‐specifically predicts mortality in decompensated cirrhosis (2019) (18)
Aspirin resistance and diabetic angiopathy: back to the future. (2004) (18)
Hereditary Deficiency of gp 91 phox Is Associated With Enhanced Arterial Dilatation Results of a Multicenter Study (2009) (18)
Low Rate of Intrahospital Deep Venous Thrombosis in Acutely Ill Medical Patients: Results From the AURELIO Study (2019) (17)
'Real-world' observational studies in arrhythmia research: data sources, methodology, and interpretation. A position document from European Heart Rhythm Association (EHRA), endorsed by Heart Rhythm Society (HRS), Asia-Pacific HRS (APHRS), and Latin America HRS (LAHRS). (2019) (17)
Influence of Vitamin E on Plasma Malondialdehyde- Like Material in Man (1984) (17)
Interrelation between factor VII, prekallikrein, and hyperfibrinolysis in advanced cirrhosis. (1989) (17)
Serum Levels of Vitamin E Are Associated With Early Recurrence of Atrial Fibrillation After Electric Cardioversion (2012) (17)
Interplay between Oxidative Stress and Platelet Activation in Coronary Thrombus of STEMI Patients (2018) (17)
Clinical trial: low plasma cholesterol and oxidative stress predict rapid virological response to standard therapy with peginterferon and ribavirin in HCV patients (2009) (17)
Antioxidants and atherosclerosis (2002) (17)
Cholesterol-adjusted vitamin E serum levels are associated with cardiovascular events in patients with non-valvular atrial fibrillation. (2013) (17)
Giant cell arteritis, oculomotor nerve palsy, and acute hearing loss (2004) (17)
Role of platelets in NOX2 activation mediated by TNFα in heart failure (2014) (17)
SARS-CoV-2 and myocardial injury: a role for Nox2? (2020) (17)
Long-Term Risk of Major Adverse Cardiac Events in Atrial Fibrillation Patients on Direct Oral Anticoagulants. (2020) (17)
Should all acutely ill medical patients be treated with antithrombotic drugs? (2013) (16)
Age-related increase of thromboxane B2 and risk of cardiovascular disease in atrial fibrillation (2016) (16)
Spleen dimensions are inversely associated with lysosomal acid lipase activity in patients with non-alcoholic fatty liver disease (2017) (16)
Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Advanced Liver Disease: An Exploratory Meta‐Analysis (2020) (16)
Statins as regulators of redox signaling in platelets. (2014) (16)
Serum albumin and risk of cardiovascular events in primary and secondary prevention: a systematic review of observational studies and Bayesian meta-regression analysis (2019) (16)
Enhanced NOX-2 derived oxidative stress in offspring of patients with early myocardial infarction. (2019) (16)
Atrial fibrillation and human immunodeficiency virus type‐1 infection: a systematic review. Implications for anticoagulant and antiarrhythmic therapy (2019) (16)
The polyphenols quercetin and catechin synergize in inhibiting platelet CD40L expression (2005) (16)
Aspirin Reload Before Elective Percutaneous Coronary Intervention: Impact on Serum Thromboxane B2 and Myocardial Reperfusion Indexes (2014) (16)
Pain and Frailty in Hospitalized Older Adults (2020) (15)
Association of different oral anticoagulants use with renal function worsening in patients with atrial fibrillation: A multicentre cohort study (2020) (15)
Endotoxemia as a trigger of thrombosis in cirrhosis (2016) (15)
Does enhancement of oxidative stress markers mediate health effects of ambient air particles? (2014) (15)
Effect on walking distance and atherosclerosis progression of a nitric oxide-donating agent in intermittent claudication. (2012) (15)
Antiplatelet Treatment With Ticlopidine in Unstable Angina (2005) (15)
Superoxide Anion Scavenging Property of Dipyridamole (1989) (15)
Antioxidant treatment decreases the titer of circulating anticardiolipin antibodies: comment on the article by Sambo et al. (2002) (15)
Statin treatment as a confounding factor in human trials with vitamin E. (2008) (15)
Statin use and mortality in atrial fibrillation: a systematic review and meta-analysis of 100,287 patients. (2021) (15)
Relationship of Antiphospholipid Antibodies to Risk of Dementia: A Systematic Review. (2019) (15)
Serum Cytokeratin-18 Is Associated with NOX2-Generated Oxidative Stress in Patients with Nonalcoholic Fatty Liver (2014) (15)
Interventional study with vitamin E in cardiovascular disease and meta-analysis. (2021) (15)
Nox2‐mediated platelet activation by glycoprotein (GP) VI: Effect of rivaroxaban alone and in combination with aspirin (2019) (15)
Lysosomal acid lipase activity and liver fibrosis in the clinical continuum of non‐alcoholic fatty liver disease (2019) (15)
Thrombocytopenia and Mortality Risk in Patients With Atrial Fibrillation: An Analysis From the START Registry (2019) (14)
Antiphospholipid syndrome and anticoagulation quality: a clinical challenge. (2016) (14)
Effect of ramipril and vitamin E on atherosclerosis. (2002) (14)
Relationship between lipoprotein(a) levels in serum and some indices of protein synthesis in liver cirrhosis. (1994) (14)
Enhanced Soluble Serum CD40L and Serum P-Selectin Levels in Primary Aldosteronism (2016) (14)
Joint use of cardio-embolic and bleeding risk scores in elderly patients with atrial fibrillation. (2013) (14)
Systemic clotting activation by low-grade endotoxaemia in liver cirrhosis: a potential role for endothelial procoagulant activation. (1997) (14)
Prekallikrein behaviour in chronic active hepatitis and in cirrhotic patients. (1984) (14)
Thrombocytopenia and Mortality Risk in Patients With Atrial Fibrillation: An Analysis From the START Registry (2019) (14)
Treatment of a patient with congenital analbuminemia with atorvastatin and albumin infusion. (2013) (14)
Arterial and venous thrombosis in coronavirus 2019 disease (Covid-19): relationship with mortality (2021) (14)
Proprotein Convertase Subtilisin Kexin Type 9 Inhibitors Reduce Platelet Activation Modulating ox-LDL Pathways (2021) (14)
Role of NADPH oxidase-2 and oxidative stress in children exposed to passive smoking (2018) (14)
A novel role of MMP2 in regulating platelet NOX2 activation. (2020) (13)
Moderate Weight Loss Decreases Oxidative Stress and Increases Antioxidant Status in Patients with Metabolic Syndrome (2012) (13)
Inhibition by picotamide of thromboxane production in vitro and ex vivo (2004) (13)
Brain and kidney, victims of atrial microembolism in elderly hospitalized patients? Data from the REPOSI study. (2015) (13)
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study (2018) (13)
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry (2020) (13)
Impaired flow-mediated dilation in hospitalized patients with community-acquired pneumonia. (2016) (13)
Anticardiolipin Antibodies and Prostacyclin Synthesis (1987) (13)
Aspirin resistance: is this term meaningful? (2006) (13)
Early decrease of oxidative stress by non-invasive ventilation in patients with acute respiratory failure (2018) (12)
Ticlopidine in unstable angina. (1990) (12)
Blood hydrogen peroxide break-down activity in healthy subjects and in patients at risk of cardiovascular events. (2018) (12)
Should the term coagulopathy in cirrhosis be abandoned? (2015) (12)
The Atrial fibrillation Better Care (ABC) pathway and cardiac complications in atrial fibrillation: a potential sex-based difference. The ATHERO-AF study. (2020) (12)
Time to therapeutic range (TtTR), anticoagulation control, and cardiovascular events in vitamin K antagonists–naive patients with atrial fibrillation (2018) (12)
Relationship between Mediterranean diet and time in therapeutic range in atrial fibrillation patients taking vitamin K antagonists. (2015) (12)
Left Atrium Dilatation and Left Ventricular Hypertrophy Predispose to Atrial Fibrillation in Patients With Community-Acquired Pneumonia. (2019) (12)
Hepatitis C virus, antiphospholipid antibodies, and thrombosis (1997) (12)
Is there an association between atherosclerotic burden, oxidative stress and gut-derived lipopolysaccharides? (2020) (12)
Thrombocytopenia and thrombocytopathia in liver cirrhosis (1992) (12)
Treatment of severe hypercholesterolemia with atorvastatin in congenital analbuminemia. (2004) (12)
Is There an Interplay Between Adherence to Mediterranean Diet, Antioxidant Status, and Vascular Disease in Atrial Fibrillation Patients? (2016) (12)
Antioxidants in peripheral arterial disease. (2004) (12)
A Hypothesis-Generating Study of the Combination of Aspirin plus Macrolides in Patients with Severe Community-Acquired Pneumonia (2018) (12)
Antioxidant activity from extra virgin olive oil via inhibition of hydrogen peroxide-mediated NADPH-oxidase 2 activation. (2018) (11)
Effect of aspirin on renal disease progression in patients with type 2 diabetes: A multicenter, double-blind, placebo-controlled, randomized trial. The renaL disEase progression by aspirin in diabetic pAtients (LEDA) trial. Rationale and study design. (2017) (11)
Interaction between serum endotoxemia and proprotein convertase subtilisin/kexin 9 (PCSK9) in patients with atrial fibrillation: A post-hoc analysis from the ATHERO-AF cohort. (2019) (11)
A diagnostic approach to ischemic stroke in young and middle‐aged adults (1996) (11)
35th Annual meeting of the European Association for the Study of Diabetes. Brussels, Belgium, 28 September-2 October, 1999. Abstracts. (1999) (11)
Determinants of low‐quality warfarin anticoagulation in patients with mechanical prosthetic heart valves. The nationwide PLECTRUM study (2020) (11)
Cancer and atrial fibrillation: Epidemiology, mechanisms, and anticoagulation treatment. (2021) (11)
Concepts and Controversies in Haemostasis and Thrombosis Associated with Liver Disease : Proceedings of the 7 th International Coagulation in Liver Disease Conference October 6 th and 7 th , 2017 Rome , Italy (2018) (10)
Ultrasonography (US) and non-invasive diagnostic methods for non-alcoholic fatty liver disease (NAFLD) and early vascular damage. Possible application in a population study on the metabolic syndrome (MS) (2012) (10)
Early increase of NOX2-derived oxidative stress in children: relationship with age (2013) (10)
Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. (2010) (10)
Polyunsaturated fatty acids balance affects platelet NOX2 activity in patients with liver cirrhosis. (2014) (10)
Aspirin and renal insufficiency progression in patients with atrial fibrillation and chronic kidney disease. (2016) (10)
Endotoxaemia, hyperfibrinolysis, and bleeding in cirrhosis (1999) (10)
Passive Smoking Exacerbates Nicotinamide‐Adenine Dinucleotide Phosphate Oxidase Isoform 2–Induced Oxidative Stress and Arterial Dysfunction in Children with Persistent Allergic Rhinitis (2018) (10)
Procedure‐related bleeding risk in patients with cirrhosis and severe thrombocytopenia (2021) (10)
Reduced Lysosomal Acid Lipase Activity in Blood and Platelets Is Associated With Nonalcoholic Fatty Liver Disease (2020) (10)
Thrombosis in Covid-19 and non-Covid-19 pneumonia: role of platelets (2021) (9)
Management of Patients with Asymptomatic and Symptomatic Carotid Artery Disease: Update on Anti-Thrombotic Therapy (2019) (9)
Update and Unmet Needs on the Use of Nonvitamin K Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation. (2019) (9)
Iron, platelet function, and coronary heart disease: a possible link? (1993) (9)
Impact of chronic use of heat-not-burn cigarettes on oxidative stress, endothelial dysfunction and platelet activation: the SUR-VAPES Chronic Study (2021) (9)
Plasma thiobarbituric acid reactive substances a predictive marker of cerebral ischemia in patients at high risk? (1991) (9)
Activation of platelet cyclooxygenase by red cells in vitro. (1985) (9)
Predictors of Renal Function Worsening in Patients with Chronic Obstructive Pulmonary Disease (COPD): A Multicenter Observational Study (2021) (9)
Effects of Ticlopidine on Platelet Function and Blood Coagulation (1982) (9)
Oxygen free radical-dependent increased platelet function in beta-thalassemia major patients. (1998) (9)
Aspirin in asymptomatic patients with a confirmed positivity of antiphospholipid antibodies (2008) (9)
Glucocorticoids impair platelet thromboxane biosynthesis in community‐acquired pneumonia (2018) (9)
Effect of oral defibrotide on tissue-plasminogen activator and tissue-plasminogen activator inhibitor balance (1992) (9)
Hazelnut and cocoa spread improves flow-mediated dilatation in smokers (2018) (9)
Human platelet aggregation by PAF and thromboxane production. (1987) (8)
A simple method for evaluating platelet superoxide dismutase. (1985) (8)
Oleuropein-enriched chocolate by extra virgin olive oil blunts hyperglycaemia in diabetic patients: Results from a one-time 2-hour post-prandial cross over study. (2020) (8)
Soluble CD 40 Ligand Predicts Ischemic Stroke and Myocardial Infarction in Patients With Nonvalvular Atrial Fibrillation (2007) (8)
NOX 5 is expressed in platelets from patients with chronic granulomatous disease (2016) (8)
LONG-TERM OXYGEN AND ADVANCED CHRONIC BRONCHITIS (1981) (8)
In Vitro Effect of Vitamin E and Butylated Hydroxytoluene on Plasma ’ Malondialdehyde-Like Material Formation (1986) (8)
Tailored Practical Management of Patients With Atrial Fibrillation: A Risk Factor-Based Approach (2019) (8)
Portal levels of the isoprostane F2 alpha-III, a marker of lipid peroxidation, do not correlate with increased portal pressure in cirrhotic patients. (1998) (8)
Clotting Activation after Transjugular Intrahepatic Portosystemic Stent Shunt (1999) (8)
Blood lipid peroxides in TIA: relation to platelet function and metabolic profile (1989) (8)
Comparison of thrombotic events and mortality in patients with community-acquired pneumonia and COVID-19: a multicentre observational study (2021) (8)
Antioxidant strategy for cardiovascular disease (2001) (8)
Digoxin and Platelet Activation in Patients With Atrial Fibrillation: In Vivo and In Vitro Study (2018) (7)
Prognostic and therapeutic implications of vascular disease in patients with atrial fibrillation (2018) (7)
Effect of corticosteroids on myocardial injury among patients hospitalized for community-acquired pneumonia: rationale and study design. The colosseum trial (2019) (7)
Antioxidant supplements and cardiovascular disease in men. (2009) (7)
Atrial fibrillation pattern, left atrial diameter and risk of cardiovascular events and mortality. A prospective multicenter cohort study (2020) (7)
Moderate alcohol use and health: A consensus paper (2013) (7)
Prevalence and Impact of Nonalcoholic Fatty Liver Disease in Atrial Fibrillation. (2019) (7)
Synergistic beneficial effects of natural activators of autophagy on endothelial cells and platelets. (2021) (7)
Polyphenolic antioxidants and health (2012) (7)
Fibrinogen as predictor of ischemic stroke in patients with non‐valvular atrial fibrillation (2003) (7)
A critical review of antiplatelet treatment in peripheral arterial disease (2007) (7)
Antiphospholipid antibodies, hypercoagulability and thrombosis. (1995) (7)
Hypoalbuminemia and clinical adverse events in children with COVID‐19 (2021) (7)
WERNICKE ENCEPHALOPATHY—AN EMERGING TREND AFTER BARIATRIC SURGERY (2004) (6)
Data on incidence of bleeding in patients with atrial fibrillation and advanced liver fibrosis on treatment with vitamin K or non-vitamin K antagonist oral anticoagulants (2018) (6)
Interventional trials with anticoagulants in acutely ill medical patients: a methodological pitfall? (2013) (6)
On-Treatment Platelet Reactivity is a Predictor of Adverse Events in Peripheral Artery Disease Patients Undergoing Percutaneous Angioplasty. (2018) (6)
Thrombosis in pre- and post-vaccination phase of COVID-19 (2021) (6)
The need for a consistent definition of ‘aspirin resistance’ (2006) (6)
COVID-19 and thrombosis: Clinical features, mechanism of disease, and therapeutic implications. (2021) (6)
Fibrinolytic balance and lupus anticoagulant in patients with repeated spontaneous fetal loss. (1992) (6)
Uptake of oxidized LDL by human atherosclerotic plaque. (1997) (6)
An observed association between conjunctivitis and severity of COVID-19. (2021) (6)
Inhibition of cyclooxygenase-independent platelet aggregation by sodium salicylate. (1989) (6)
Toll-like receptor 4 activation in platelets from myocardial infarction patients (2021) (6)
Anticoagulation in patients with advanced liver disease: an open issue (2020) (6)
C2238 ANP gene variant promotes increased platelet aggregation through the activation of Nox2 and the reduction of cAMP (2017) (6)
Pentraxin 3 - A Link Between Obesity, Inflammation and Vascular Disease? (2016) (6)
Lupus Anticoagulant in Liver Cirrhosis (1988) (6)
Cancer‐specific ischemic complications in elderly patients with atrial fibrillation: Data from the prospective ATHERO‐AF study (2020) (6)
In vivo thrombin generation and platelet hyperactivity in patients with chronic obstructive pulmonary disease. (1994) (6)
Hageman factor, high molecular weight kininogen, and prekallikrein in chronic liver disease. (1986) (6)
Oxidative stress and gut-derived lipopolysaccharides in children affected by paediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (2019) (6)
Nutritional and therapeutic approaches to modulate NADPH oxidase-derived ROS signaling in platelets. (2015) (6)
Extra Virgin Olive Oil Reduces Gut Permeability and Metabolic Endotoxemia in Diabetic Patients (2022) (5)
[Oxidative stress and hypercholesterolemia: increase of radical hydroxyl in patients with hypercholesterolemia]. (1999) (5)
Specificity and sensitivity of diluted aPTT and anticardiolipin antibodies towards thrombosis and miscarriages in patients with systemic lupus erythematosus. (1990) (5)
Impaired Clinical Efficacy of Aspirin in Hypoalbuminemic Patients With Diabetes Mellitus (2021) (5)
Dipyridamole potentiates the inhibition of platelet aggregation by aspirin (in human platelet rich plasma and whole blood). (1991) (5)
Successful removal of antiphospholipid antibodies using repeated plasma exchanges and prednisone. (1989) (5)
Platelets and oxygen radicals: mechanisms of functional modulation. (2001) (5)
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids. (2019) (5)
THE ADA (AGE-D-DIMER-ALBUMIN) SCORE TO PREDICT THROMBOSIS IN SARS-CoV-2. (2022) (5)
Beneficial effects of a combination of natural product activators of autophagy on endothelial cells and platelets (2021) (5)
Oxidative stress, antioxidants, and cardiovascular disease. (2005) (5)
Relation of Atrial Fibrillation to Angiographic Characteristics and Coronary Artery Disease Severity in Patients Undergoing Percutaneous Coronary Intervention. (2020) (5)
Anticardiolipin antibodies possess anticoagulant activity which is blocked by a monoclonal antibody against a cross reacting idiotype of antiphospholipid antibodies. (1989) (5)
Impaired platelet activation in patients with hereditary deficiency of p47phox (2018) (5)
Increased oxidant stress in liver cirrhosis (1996) (4)
High density lipoprotein cholesterol low serum level as the only risk factor in male patients with coronary heart disease. (1992) (4)
Does the coexistence of Chronic Obstructive Pulmonary Disease and Atrial Fibrillation affect Nox2 activity and urinary isoprostanes excretion? (2019) (4)
[Role of pulmonary metabolism in blood coagulation in physiology, clinical medicine and therapy]. (1977) (4)
Low Doses of Calcium-Heparin in Liver Cirrhosis (1985) (4)
Safety of picotamide, an antiplatelet agent, in an 18-month, double-blind, placebo-controlled, multicenter trial in 2304 patients with peripheral vascular disease (1993) (4)
Increased intestinal barrier permeability in patients with moderate to severe plaque‐type psoriasis (2020) (4)
Antioxidant strategy for cardiovascular disease [1] (multiple letters) (2001) (4)
Does Regular Physical Exercise Preserve Artery Dilation by Lowering Nox2-Related Oxidative Stress? (2017) (4)
Thromboxane biosynthesis in patients with systemic lupus erythematosus (1993) (4)
Chronic granulomatous disease as an SOS call for multicenter cooperative effort to prevent infections: A meta-analysis of the treatments. (2016) (4)
Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry (2021) (4)
Non-alcoholic fatty liver disease (NAFLD), metabolic syndrome and cardiovascular events in atrial fibrillation. A prospective multicenter cohort study (2021) (4)
Comparison of the 2MACE and TIMI-AF Scores for Composite Clinical Outcomes in Anticoagulated Atrial Fibrillation Patients. (2018) (4)
Platelet activation after radiofrequency ablation in atrial fibrillation: is there any clinical implication? (2014) (4)
with systemic lupus erythematosus (letter; comment) Lupus anticoagulant and increased thrombin generation in patients (2012) (4)
Strong interplay between metabolic syndrome, obstructive sleep apnoea, oxidative stress and arterial dysfunction (2013) (4)
Clinical Cirrhosis Dilemmas: Survey of Practice from the 7th International Coagulation in Liver Disease Conference (2019) (4)
Beta-Thromboglobulin Plasma Levels in Common Migraine (1984) (4)
Vitamin C inhibits platelet lipoxygenase and cyclogenase pathways (1984) (4)
Corticosteroid use, myocardial injury and in‐hospital cardiovascular events in patients with community‐acquired pneumonia (2020) (4)
Lipopolysaccharide induces platelet activation in HIV patients: the role of different viral load patterns (2021) (3)
Gut dysbiosis, endotoxemia and clotting activation: A dangerous trio for portal vein thrombosis in cirrhosis. (2022) (3)
Enhanced Nox-2 derived oxidative stress in offspring of patients with early myocardial infarction (2020) (3)
Gut microbiota and myocardial infarction. (2020) (3)
Letter by Violi and Pignatelli regarding article, "Effects of random allocation to vitamin E supplementation on the occurrence of venous thromboembolism: report from the Women's Health Study". (2008) (3)
Asymptomatic and symptomatic deep venous thrombosis in hospitalized acutely ill medical patients: risk factors and therapeutic implications (2022) (3)
Different rates of conjunctivitis in COVID-19 eastern and western hospitalized patients: a meta-analysis (2021) (3)
Oxidative stress in the pathogenesis/treatment of atherosclerosis (2007) (3)
Potential usefulness of antiplatelet agents in patients with chronic obstructive pulmonary disease. (1996) (3)
1013-109 Effect of Picotamide in Preventing Cardiovascular Events in 438 Diabetic Patients: Results of a Multi-Centre, Placebo Controlled, 18-Month Study (1995) (3)
Hemostasis in chronic liver disease (2006) (3)
Improvement of blood gas levels after calcium-heparin treatment in patients with chronic obstructive pulmonary disease. (1992) (3)
Clinical Trials with Vitamin E in Cardiovascular Disease: Are they Meaningful? (2001) (3)
Full versus prophylactic-intermediate doses of anticoagulants in COVID-19: a meta-analysis (2022) (3)
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY Vitamin E Reduces Monocyte Tissue Factor Expression in Cirrhotic Patients (1999) (3)
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients. (2019) (3)
Erratum to: Portal vein thrombosis relevance on liver cirrhosis: Italian Venous Thrombotic Events Registry (2016) (3)
Antithrombotic drugs in acutely ill medical patients: review and meta-analysis of interventional trials with low-molecular-weight heparin and fondaparinux (2013) (3)
Future Directions in Clinical Vitamin E Research: Panel Discussion B (2004) (2)
Determinants of fibrinogen in an Italian population suffering from claudication. Lower fibrinogen in the south compared to middle and north of Italy. The ADEP Group. (1998) (2)
Abstract 5454: Oxidative Stress is Associated with Arterial Dysfunction and Enhanced Intima-Media Thickness in Children with Hypercholesterolemia. Potential Role of Nadph Oxidase (2008) (2)
Lights and shadows in the management of old and new oral anticoagulants in the real world of atrial fibrillation by Italian internists. A survey from the Atrial Fibrillation Registry for Ankle-Brachial Index Prevalence Assessment-Collaborative Italian Study. (2015) (2)
Blood lipid abnormalities in patients suffering from peripheral vascular disease. (1988) (2)
Future Directions in Preclinical Vitamin E Research: Panel Discussion A (2004) (2)
Introduction to nutraceuticals special issue. (2010) (2)
Poor vitamin B6 status: a novel potential thrombotic factor in chronic obstructive pulmonary disease. (2010) (2)
The Sodium–Glucose Co-Transporter-2 (SGLT2) Inhibitors Reduce Platelet Activation and Thrombus Formation by Lowering NOX2-Related Oxidative Stress: A Pilot Study (2022) (2)
The thrombogenic risk in chronic respiratory failure. (1984) (2)
University of Groningen Concepts and Controversies in Haemostasis and Thrombosis Associated with Liver Disease faculty of the 7th International Coagulation in Liver Disease (2018) (2)
Radiolabeled native LDL injected into patients with carotid stenosis accumulates in the macrophages of atherosclerotic plaque: Effect of vitamin E supplementation (2000) (2)
How to concile bleeding and thrombotic tendency in liver cirrhosis? (2006) (2)
Reply: platelets interplay between pneumonia and cardiovascular events: establishing a link? (2015) (2)
Heart failure and chronic kidney disease in a registry of internal medicine wards (2014) (2)
Waves of SARS-CoV-2 Infection and Blood Coagulation—A Link and Beyond (2021) (2)
Anti-D4GDI antibodies activate platelets in vitro: a possible link with thrombocytopenia in primary antiphospholipid syndrome (2019) (2)
Aging-Related Decline of Autophagy in Patients with Atrial Fibrillation—A Post Hoc Analysis of the ATHERO-AF Study (2022) (2)
Clinical risk factors and subclinical target organ damage as predictors of new-onset of atrial fibrillation: the Catanzaro atrial fibrillation project. (2014) (2)
Intravascular clotting activation and systemic hyperfibrinolysis in patients with severe liver cirrhosis: The role of ascites (1994) (2)
Effect of vitamins E and C on transplant-associated atherosclerosis (2002) (2)
Aspirin resistance (2006) (2)
Editorial commentary: Nox2: A new challenge for antiplatelet treatment? (2018) (2)
Integrated care management of patients with atrial fibrillation-far from optimal. (2020) (2)
Metabolic Endotoxemia and Arterial Stiffness in Diabetes. (2022) (2)
LIVER, PANCREAS, AND BILIARY TRACT Association Between Low-Grade Disseminated Intravascular Coagulation and Endotoxemia in Patients With Liver Cirrhosis (1995) (2)
Nox2 up-regulation and hypoalbuminemia in patients with type 2 diabetes mellitus. (2021) (2)
Atrial fibrillation is not associated with increased risk of venous thromboembolism: Results from ARAPACIS study (2015) (2)
Reducing the risk of hospital admission: a call to action from the Italian Society of Internal Medicine. (2015) (2)
Reply: platelet activation and pneumonia: is soluble p-selectin the right marker? (2015) (2)
Association between venous and arterial thrombosis (2008) (2)
Underdiagnosis and undertreatment of osteoporotic patients admitted in internal medicine wards in Italy between 2010 and 2016 (the REPOSI Register) (2021) (2)
Antiphospholipid antibodies in end‐stage renal disease: A systematic review and meta‐analysis (2020) (1)
TANDEM Digital Audio Amplifier (2004) (1)
カルニチンはアラキドン酸代謝回転,血小板機能,および酸化ストレスを阻害する (2003) (1)
[The future prospects of antithrombotic therapy in peripheral vasculopathy]. (1999) (1)
PO4-91 LDL-CHOLESTEROL ENHANCES PLATELET RECRUITMENT VIA GP91PHOX-MEDIATED CD40L UPREGULATION (2007) (1)
SAT-002-Lusutrombopag is a safe treatment option for thrombocytopenia in patients with chronic liver disease undergoing an invasive procedure: Pooled safety analysis from 3 studies (2019) (1)
Toll-Like Receptor 4-Dependent Platelet-Related Thrombosis in SARS-CoV-2 Infection (2023) (1)
Enhanced urinary excretion of thromboxane B2 in non-alcoholic fatty liver disease. Implication for antiplatelet treatment (2018) (1)
Letter by Violi et al regarding article, "molecular imaging of inflammation and platelet adhesion in advanced atherosclerosis effects of antioxidant therapy with NADPH oxidase inhibition". (2013) (1)
Sex-Related Differences in Oxidative, Platelet, and Vascular Function in Chronic Users of Heat-not-Burn vs. Traditional Combustion Cigarettes (2022) (1)
Antiplatelet Drugs in the Management of Thrombotic/Ischemic Events in Peripheral Artery Disease (2019) (1)
Anticoagulation improves survival in patients with cirrhosis and portal vein thrombosis: The IMPORTAL competing-risk meta-analysis. (2023) (1)
Letter by Violi et al regarding article, "Association of cyclooxygenase-1-dependent and -independent platelet function assays with adverse clinical outcomes in aspirin-treated patients presenting for cardiac catheterization". (2010) (1)
Should we use anticoagulant drugs to treat portal vein thrombosis in patients with liver cirrhosis? (2009) (1)
Serum albumin, clotting activation and COVID-19 severity: a systematic review and meta-regression analysis of 4579 patients (1)
Multiple Arterial Thrombosis in Seronegative Antiphospholipid Syndrome: Need for New Diagnostic Criteria? (2019) (1)
Letter by Violi et al Regarding Article, "Rivaroxaban Reduces Arterial Thrombosis by Inhibition of Fxa-Driven Platelet Activation via Protease Activated Receptor-1". (2020) (1)
Family History of Atrial Fibrillation and Risk of Cardiovascular Events (2020) (1)
The Impact of Pharmacokinetic Interactions With Eslicarbazepine Acetate Versus Oxcarbazepine and Carbamazepine in Clinical Practice: Erratum. (2016) (1)
Blood lipid profile in healthy subjects treated with ticlopidine. (1985) (1)
[Platelet aggregation and blood letting in subjects suffering from chronic respiratory insufficiency with polyglobulia]. (1977) (1)
Erratum: "Antioxidants in peripheral arterial disease" (Current Drug Targets - Cardiovascular & Haematological Disorders vol. 4 (3) (290)) (2004) (1)
Risk of cardiovascular events in patients with atrial fibrillation and cancer. Data from the ATHERO-AF cohort (2020) (1)
Systemic cause of unstable atherosclerotic plaques (2000) (1)
Peripheral Arterial Disease and Oxidative Stress (2007) (1)
Structure, Activation, and Regulation of NOX2: At the Crossroad between the Innate Immunity and Oxidative Stress-Mediated Pathologies (2023) (1)
ModerateWeight Loss Decreases Oxidative Stress and Increases Antioxidant Status in Patients with Metabolic Syndrome (2014) (1)
Abstract 12412: Platelet Isoprostane Over-Production Enhances Platelet Function in Diabetic Patients Treated with Aspirin (2011) (1)
Nocturnal rise of urinary thromboxane B2 in patients with coronary artery disease (2005) (1)
SIXTUS study group : SIXTUS ( thromboSIs-related eXTra-pulmonary oUtcomeS in pneumonia ) study group : (2016) (1)
Relationship between platelet cyclooxygenase pathway and plasma malondialdehyde-like material (1985) (1)
Blood coagulation consumption in a patient with autoimmune chronic active hepatitis. (1984) (1)
Assessment of blood hydrogen peroxide break-down activity (HBA) in healthy subjects and in patients with atrial fibrillation: relation to cardiovascular events (2018) (1)
URINARY ISOPROSTANES PREDICT VASCULAR EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION: A PROSPECTIVE STUDY (2014) (1)
Correction: Cholesterol lowering trials in coronary heart disease: frequency of citation and outcome (1992) (1)
Antioxidants in peripheral arterial disease. (2003) (1)
PO22-692 OXIDATIVE STRESS-MEDIATED PLATELET CD40 LIGAND UPREGULATION IN PATIENTS WITH HYPERCHOLESTEROLEMIA. EFFECT OF ATORVASTATIN (2007) (1)
"The portal vein in patients with cirrhosis is not an excessively inflammatory or hypercoagulable vascular bed, a prospective cohort study": comment from Violi et al. (2023) (1)
Premature coronary disease in systemic lupus. (2004) (1)
Real-world efficacy and safety of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation (2019) (1)
Coagulopathy of chronic liver disease. (2011) (1)
Antiplatelet activity of dipyridamole in cyclooxygenase independent platelet aggregation (1991) (1)
MRC/BHF Heart protection study. Authors' reply (2002) (1)
Fibrinopeptide A behaviour in chronic active hepatitis patients. (1984) (1)
P1049 : Lysosomal Acid Lipase activity in patients with non-alcoholic fatty liver disease (2015) (1)
Antioxidants and ischaemic heart disease (1997) (1)
[The effect of vitamin E on platelet aggregation and lipid pattern]. (1982) (1)
Blood Hormones and Venous Thromboembolic Events: Lack of Association or Lack of Standardization? (2018) (1)
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register (2019) (1)
Correlation between hepatic blood flow and coagulation indices in chronic active hepatitis and liver cirrhosis patients. (1985) (1)
Vitamin E and other antioxidants in the prevention of cardiovascular disease (2004) (1)
Erratum to: Medication prescription and adherence disparities in non valvular atrial fibrillation patients: an Italian portrait from the ARAPACIS study (2014) (1)
The platelets behaviour in non-alcoholic fatty liver disease. A potential role for antiplatelets drugs? (2020) (1)
Hospitalization for pneumonia and risk of cardiovascular disease. (2015) (1)
PF699 LUSUTROMBOPAG IS A SAFE TREATMENT OPTION FOR THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC LIVER DISEASE UNDERGOING A SCHEDULED INVASIVE PROCEDURE: POOLED SAFETY ANALYSIS FROM 3 STUDIES (2019) (1)
Alirocumab after Acute Coronary Syndrome. (2019) (1)
[Clinical management of older, frail patients with atrial fibrillation. Operative strategies from a multidisciplinary expert group]. (2021) (1)
2.P.329 Hydrogen peroxide involvement in platement activation induced by collagen (1997) (1)
Hagemanfactor, highmolecular weight kininogen, andprekallikrein inchronic liver disease (1986) (1)
Low-grade endotoxemia and NOX-2 in patients with coronary microvascular angina. (2022) (1)
Role of aspirin in patients with septic shock: a complex and intriguing relationship (2016) (1)
Correction to: Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study (2018) (1)
HCV clearance and pro-thrombotic shift in advanced liver disease (2018) (1)
Sex‐based difference in anticoagulated patients with mechanical prosthetic heart valves and long‐term mortality risk (2021) (1)
Association between right ventricular dysfunction and adverse cardiac events in mild COPD patients (2022) (1)
Reply: myocardial infarction in patients with pneumonia. (2015) (1)
Reply: ankle-brachial index in patients with nonvalvular atrial fibrillation. (2014) (1)
Clinical trials with ADP receptor antagonists. (2000) (1)
Early anticoagulant effect of atorvastatin. (2005) (0)
Lysosomal Acid Lipase Activity And Hepatic Fibrosis In Non-Alcoholic Fatty Liver Disease (2019) (0)
Increased thrombin generation in patients with chronic gastritis and helicobacter pylori infection (2000) (0)
High Power Step-Up Converter for Car Subwoofers (2004) (0)
Editorial: Gut permeability-related endotoxemia and cardiovascular disease: A new clinical challenge (2023) (0)
The expert in hemostasis and thrombosis in the Italian health system: role and requirements for a specific clinical and laboratory expertise (2013) (0)
D40 Ligand Enhances onocyte Tissue Factor Expression nd Thrombin Generation Via Oxidative tress in Patients With Hypercholesterolemia (2004) (0)
F028: Increased platelet release of superoxide anion in hypertensives (2000) (0)
Abstract 11511: Metabolic Syndrome is an Independent Predictor of Cardiovascular Events in Patients With Atrial Fibrillation (2013) (0)
Low serum albumin is associated with mortality and arterial and venous ischemic events in acutely ill medical patients. Results of a retrospective observational study. (2023) (0)
C2238 ANP gene variant promotes increased platelet aggregation through the activation of Nox2 and the reduction of cAMP (2017) (0)
[Possible relationships between platelet aggregation and hematocrit values]. (1978) (0)
Rationale for the use of antiplatelet drugs in patients with peripheral vascular disease. (1994) (0)
Metabolic Syndrome is an Independent Predictor of Cardiovascular Events in Patients With Atrial Fibrillation (2013) (0)
Influence of oral defibrotide administration on fibrinolytic system in atherosclerotic patients (1991) (0)
Abstract 16055: Ongoing Prothrombotic State in the Early Phase of Pneumonia (2015) (0)
New Insight Into Platelet Activation and Thrombosis: Is There a Role for IL-37? (2023) (0)
PO10-287 EARLY INCREASE OF OXIDATIVE STRESS AND SOLUBLE CD40L IN CHILDREN (2007) (0)
Tu-W26:5 Relationship between platelet CD40 ligand expression and platelet superoxide anion in hypercholesterolemia. Effect of atorvastatin (2006) (0)
Liver fibrosis and cardiovascular events in non-alcoholic fatty liver disease. The prospective cohort plinio study (2020) (0)
Reply to Chen and Vitetta (2022) (0)
P312digoxin and platelet activation in atrial fibrillation patients (2018) (0)
Antioxidant Supplements and Cardiovascular Disease in Men. Authors' reply (2009) (0)
[Prostaglandins and ischemic cardiopathy]. (1992) (0)
Abstract 360: Rivaroxaban Enhances the Antiplatelet Activity of Aspirin via Inhibition of Nox2-mediated Thromboxane A 2 and Isoprostane Biosynthesis (2018) (0)
[Platelet aggregation and bloodletting in normal subjects]. (1978) (0)
Free radicals-mediated activation of platelets exposed to anoxia and reoxygenation (1996) (0)
In Memoriam Hymie L. Nossel (1984) (0)
Clinical phenotypes of atrial fibrillation and risk of mortality: a cluster analysis (2020) (0)
Superoxide anion production and aggregation capacity by platelets in surgical trauma under general anaesthesia: A-340 (2004) (0)
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both (2023) (0)
Association between PaO2/FiO2 ratio and thrombotic events in COVID-19 patients (2023) (0)
Aspirin (2004) (0)
P1733Proprotein convertase subtilisin/kexin type 9 (PCSK9), platelet activation and risk of cardiovascular events in atrial fibrillation (2017) (0)
[Leukocyte activation in cerebral ischemia]. (1988) (0)
[Erythrocyte deformability in chronic respiratory insufficiency]. (1983) (0)
Clinical risk factors and subclinical target organ damage as predictors of new-onset of atrial fibrillation (2014) (0)
Abstract: P318 ENHANCED PLATELET ACTIVATION INDEXES IN ATRIAL FIBRILLATION PATIENTS: ROLE OF COEXISTING ATHEROSCLEROTIC RISK FACTORS (2009) (0)
Localization of lipopolysaccharide from Escherichia Coli into human atherosclerotic plaque (2018) (0)
Erratum: Potential usefulness of antiplatelet agents in patients with chronic obstructive pulmonary disease (Thrombosis Research 84, No. 4, pp. 279-284, 1996) (1997) (0)
Ticlopidine as antiplatelet therapy for unstable angina (1991) (0)
Different sensitivity to thrombosis of four coagulation tests detecting lupus anticoagulant (LA) in patients affected from systemic lupus erythematosus (SLE) (1991) (0)
Abstract No. 616 Lusutrombopag is a safe treatment option for thrombocytopenia in patients with chronic liver disease undergoing a planned invasive procedure: pooled safety analysis from three studies (2020) (0)
Low Grade Endotoxemia and Oxidative Stress in Offspring of Patients with Early Myocardial Infarction (2023) (0)
Clinical Trials of Ticlopidine in Patients with Coronary Artery Disease (1993) (0)
451 NADPH OXIDASE-RELATED OXIDATIVE STRESS ENHANCES PLATELET THROMBOXANE PRODUCTION IN ASPIRIN-TREATED PATIENTS UNDERGOING ELECTIVE PERCUTANEOUS CORONARY INTERVENTION (2011) (0)
32 Prevalenced of portal vein thrombosis (PVT) and associated factors in cirrhotic patients (2003) (0)
Reply to: "Inadequate anticoagulation by vitamin K antagonists and major adverse cardiovascular events other than stroke". (2016) (0)
Reply: LDL-Cholesterol and Atherosclerotic Cardiovascular Disease: Innocent Bystander or Essential Ingredient? (2018) (0)
Anti-Xa plasma activity in liver cirrhosis:Relation with antithrombin III and alpha1-antitripsin (1986) (0)
Sharing Clinical Data. (2016) (0)
CYCLOOXYGENASE INDIPENDENT PLATELET AGGREGATION:RELATION WITH ASPI RIN CONCENTRATION (1987) (0)
1050: ASPIRIN PLUS MACROLIDE THERAPY IN PATIENTS WITH SEVERE PNEUMONIA A MULTICENTER RETROSPECTIVE STUDY (2018) (0)
589 Oxidative Stress and Inflammation in Liver Cirrhosis: Role of N-6/N-3 Polyunsaturated Fatty Acids Balance (2012) (0)
Carnitines inhibits oxygen free radical release by endothelial cell and leukocytes (2000) (0)
Response to "Digoxin or digoxin prescribed patient? Randomized trials are essential to discriminate the principal risk factor for the association of digoxin and increased mortality". (2015) (0)
Stimulation of platelet aggregation by H202 (1991) (0)
Short‐term in vivo modifications of platelet NADPH oxidase 2 (NOX2) and prostaglandin F2α in HIV‐1 patients on abacavir‐based therapies (2016) (0)
External validation of the ADA score for predicting thrombosis among acutely ill hospitalized medical patients from the APEX Trial (2022) (0)
Abnormalities of primary hemostasis in patients with liver cirrhosis (1993) (0)
Increased gut permeability is associated with oxidative stress in patients with NAFLD (2018) (0)
ASYMPTOMATIC EXTRACRANIAL CAROTID ATHEROSCLEROSIS AND RISK FOR CEREBROVASCULAR EVENTS IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION: THE ARAPACIS STUDY (2016) (0)
Long-Term Spasticity Management in Post-Stroke Patients: Issues and Possible Actions—A Systematic Review with an Italian Expert Opinion (2023) (0)
Spleen Dimensions Evaluated by Ultrasound are Inversely Associated with Lysosomal Acid Lipase Activity in Patients with Non-Alcoholic Fatty Liver Disease (2016) (0)
A polyphenol mixture inhibits collagen induced platelet aggregation (2003) (0)
Abstract 19927: Over-Treatment with Oral Anticoagulants of Non Valvular Atrial Fibrillation Patients at Low Risk of Stroke: The ARAPACIS Study (2014) (0)
1016 Lusutrombopag Is a Safe Treatment Option for Thrombocytopenia in Patients With Chronic Liver Disease Undergoing a Scheduled Invasive Procedure: Pooled Safety Analysis From 3 Studies (2019) (0)
Abstract: P687 INHERITED HUMAN GP 91PHOX DEFICIENCY IS ASSOCIATED WITH IMPAIRED ISOPROSTANE FORMATION AND REDUCED PLATELET RECRUITMENT (2009) (0)
Long Term Oxygen and Advanced Chronic Bronchitis (1981) (0)
Polymorphism of NADPH Oxidase p 22 phox and Recurrence of Cardiovascular Events in Coronary Artery Disease (2008) (0)
Abstract 12436: Nox2-Mediated Arterial Dysfunction in Smokers: Effect of Dark Chocolate (2011) (0)
Abstract (2003) (0)
Letter by Violi et al Regarding Article, "Distinct Regulatory Effects of Myeloid Cell and Endothelial Cell NAPDH Oxidase 2 on Blood Pressure". (2017) (0)
P5506Proprotein convertase subtilisin/kexin 9 (PCSK9) and lipopolysaccharide (LPS) in patients with atrial fibrillation. A biomarker post-hoc analysis from the ATHERO-AF cohort (2019) (0)
Platelet defetcts in cirrhosis: fact or fiction? (2023) (0)
Tissue-type plasminogen activator antigen and plasminogen activator inhibitor antigen in type 2 diabetes mellitus (1989) (0)
Author reply to comment on "Bleeding and thrombosis in cirrhotic patients: What really matters?" (2012) (0)
BEHAVIOUR OF ADREN0CHR0ME PATHWAY IN PATIENTS WITH CEREBROVASCULAR DISEASES (1987) (0)
Mechanisms of digoxin-related platelet activation in atrial fibrillation patients: In vivo and in vitro study (2018) (0)
Abstract 153: Gut Microbiota-derived Lipolysaccarides Are Enhnaced in the Coronary Thrombi of Patients With Myocardial Infarction (2018) (0)
Endothelial dysfunction and peripheral arterial disease: reply (2007) (0)
Behaviour of vitamin e, a and c in patients with documented coronary artery disease (1993) (0)
Demand #1 - Ever Closer Union – The New Federalist (2020) (0)
University of Birmingham Clinical risk factors and subclinical target organ damage as predictors of new-onset of atrial fibrillation (2014) (0)
RelationshipbetweenMediterraneandietandtime in therapeutic range in atrial fibrillation patients taking vitamin K antagonists (2015) (0)
P825 NON-ALCOHOLIC FATTY LIVER DISEASE IS ASSOCIATED WITH REDUCED SERUM CHOLESTEROL-ADJUSTED VITAMIN E LEVELS (2014) (0)
and clinical adverse events in children with COVID ‐ (2021) (0)
P5454PCSK9 as a predictor of cardiovascular events in atrial fibrillation: role of platelet activation (2019) (0)
Effect of atorvastatin on platelet function in patients with hypercholesterolemia (2000) (0)
A Closer Look at Platelet Count and Prediction of Bleeding in Cirrhotic Patients (2018) (0)
The fenton-type OHo generating reaction activates human platelets (1991) (0)
Vitamin e serum level, a new tool to stratify bleeding risk in patients receiving oral anticoagulant therapy (2013) (0)
A messanger-like function of oxygen free radicals? A positive feedback signal given by OH° “cripto”-OH° in the platelet activation process (1993) (0)
Long term ticlopidine administration increases walking distance and ankle blood pressure in claudicants: a 2 year double blind study (1989) (0)
Abstract 452: Enhanced Soluble Cd40l As Predictor Of Vascular Events In Patients With Non-valvular Atrial Fibrillation: Results Of A Prospective Study. (2007) (0)
Abstract 15021: Ascorbic Acid Infusion Blunts Cd40l up-Regulation in Patients Undergoing Coronary Stent (2010) (0)
HISTORY OF ATRIAL FIBRILLATION IN A FIRST-DEGREE RELATIVE AND RISK OF CARDIOVASCULAR EVENTS (2017) (0)
PNPLA3 variant and portal/periportal histological pattern in patients with biopsy-proven non-alcoholic fatty liver disease: a possible role for oxidative stress (2017) (0)
Comment on "atorvastatin improves disease activity of nonalcoholic steatohepatitis partly through its tumour necrosis factor-α-lowering property". (2013) (0)
Contents Vol. 32, 2002 (2002) (0)
Identification of Different Patterns of Dabigatran In Vivo Bioactivation in Patients on Maintenance Anticoagulation Therapy. (2016) (0)
Anticoagulants in Atrial Fibrillation and Liver Disease. (2019) (0)
Abstract: P1350 OVEREXPRESSION OF MYELOPEROXIDASE IN CHILDREN WITH HYPERCHOLESTEROLEMIA (2009) (0)
Abstract 14131: Dark Chocolate Enhances Artery Dilatation Via Nox2 Down-regulation in Patients With Peripheral Arterial Disease (2013) (0)
P018 The Nox2: the new marker of stress oxidative in non-alcoholic steatohepatitis in children (2018) (0)
Abstract 16732: Urinary 11-Dehydro-Thromboxane B2 is Associated With Vascular and Non-Vascular Events in Atrial Fibrillation Patients (2014) (0)
Statins reduce major adverse limb events and mortality in patients with peripheral artery disease (2020) (0)
The Role of Nicotinamide Adenine Dinucleotide Phosphate Oxidase in the Pathogenesis of Hypertension (2009) (0)
Thromboxane biosynthesis and platelet function in patients with peripheral arterial disease (PAD) (1992) (0)
[Effects of cod liver oil on platelet aggregation and lipid parameters]. (1982) (0)
Oxidative stress and atherosclerosis: Antioxidant therapy (2001) (0)
Platelet activation by oxygen free radicals in hypercholesterolemic patients (2000) (0)
Nadph Oxidase-mediated Arterial Dysfunction in Patients With Peripheral Arterial Disease. (2009) (0)
University of Birmingham Time to therapeutic range (TtTR), anticoagulation control, and cardiovascular events in vitamin K antagonists–naive patients with atrial fibrillation Time to therapeutic range and atrial fibrillation (2018) (0)
erythematosus . miscarriage in patients with systemic lupus and their relation to thrombosis and Methods for detecting lupus anticoagulants (2004) (0)
Aspirin treatment reduces oxygen free radical release by monocytes (2001) (0)
The Atrial fibrillation Better Care (ABC) pathway is associated to a lower incidence of cardiac complications in patients with atrial fibrillation: a report from the ATHERO-AF study (2020) (0)
Low circulating levels of beta 2 gltcoprotein I (Beta 2 GPI) in patients with different degrees of liver cirrhosis (1993) (0)
Clinical use of antiplatelet therapy. (1989) (0)
A Double‐Blind Placebo‐Controlled Study: Effect of Picotamide on the Clinical Progression of Peripheral Vascular Disease (1993) (0)
Platelets in Thrombotic and Non-thrombotic Disorders: Other antiplatelet agents (2002) (0)
[Clinical experience with a new uricolytic agent]. (1986) (0)
Aspirin-Treated Patients Presenting for Cardiac Catheterization'' Independent Platelet Function Assays With Adverse Clinical Outcomes in - Dependent and - Letter by Violi et al Regarding Article, ''Association of Cyclooxygenase-1 (2012) (0)
Short-Term Treatment With Atorvastatin Reduces Platelet CD40 Ligand and Thrombin Generation in Hypercholesterolemic Patients Coronary Heart Disease (2005) (0)
Title : Early decrease of oxidative stress by atorvastatin in hypercholesterolaemic patients : effect on circulating vitamin (2007) (0)
Vasodilatation: A Pilot Study in Patients With Hereditary Nox2 Deficiency Nox2 Is Determinant for Ischemia-Induced Oxidative Stress and Arterial (2011) (0)
ANTIOXIDANTS AND ISCHAEMIC HEART DISEASE. AUTHORS' REPLY (1997) (0)
Effects of OHo scavengers on platelet aggregation (1986) (0)
ADHERENCE TO MEDITERRANEAN DIET AND NON ALCOHOLIC FATTY LIVER DISEASE: IMPACT ON METABOLIC PROFILE (2017) (0)
On-Treatment Platelet Reactivity is a Predictor of Adverse Events in Peripheral Artery Disease Patients Undergoing Percutaneous Angioplasty (2018) (0)
Letter to the Editor Statins enhance circulating vitamin E (2008) (0)
Paroxysmal nocturnal hemoglobinuria and cardio-respiratory system: new pathophysiological evidences (2020) (0)
Th-P15:147 Platelets modify LDL through GP91phox-dependent O2- formation (2006) (0)
[Effects of vitamin E administration on high-density lipoprotein cholesterol and on hypolipoproteinemia A2]. (1983) (0)
Pitfalls in assessing platelet activation status in patients with liver disease: authors’ reply (2012) (0)
Intravascular clotting activation and secondary hyperfibrinolysis in liver cirrhosis (LC) patients (1993) (0)
Reply to "The relation between flow mediated dilation and atrial fibrillation" by S. Balta: Refers to Sevket Balta, MD et al. (2015) (0)
Abstract 145: Glucocorticoid Treatment is Associated With Lower Incidence of Myocardial Infarction in Patients Hospitalized for Community-acquired Pneumonia (2018) (0)
598 IN VITRO EFFECT OF n-6/n-3 POLYUNSATURATED FATTY ACIDS ON PLATELET NOX2-MEDIATED OXIDATIVE STRESS IN LIVER CIRRHOSIS (2013) (0)
H202 evoked calcium transient in platelets (1993) (0)
Relationship between low Ankle-Brachial Index and rapid renal function decline in patients with atrial fi brillation : a prospective multicentre cohort study (2015) (0)
Reply to: Platelet function in patients with cirrhosis (2012) (0)
Tu-P10:514 GP91-phox is determinant for ischemia-induced oxidative stress and arterial vasodilatation: A clinical study (2006) (0)
Reply to: "Monitoring antivitamin K anticoagulants in antiphospholipid syndrome: A challenge in quality". (2017) (0)
P3472Modifications of renal function in atrial fibrillation patients treated with different oral anticoagulants: a multicentre cohort study (2019) (0)
INFLUENCE OF HYPERFIBRINOLYSIS ON THE PROGNOSTIC VALUE OF FACTOR VII IN PATIENTS WITH LIVER INSUFFICIENCY (1987) (0)
Aalborg Universitet Time to therapeutic range ( TtTR ) , anticoagulation control , and cardiovascular events in vitamin K antagonists – naive patients with atrial fibrillation (2018) (0)
emostatic balance in patients with liver cirrhosis : eport of a consensus conference nder the auspices of the Italian Association for the Study of Liver Diseases AISF ) and the Italian Society of Internal Medicine (2016) (0)
OP-22. Localization of isoprostane, 8-epi PGF24aL, in atherosclerotic lesions (1997) (0)
Corrigendum to "Glucocorticoids impair platelet thromboxane biosynthesis in community-acquired pneumonia" [Pharmacol. Res. 131 (2018) 66-74]. (2018) (0)
HEMOSTATIC BALANCE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY-DISEASE (1995) (0)
PO5-111 C242T POLYMORPHISM OF NADPH OXIDASE P22PHOX GENE PREDICTS MAJOR CARDIOVASCULAR EVENTS (MACE) IN HIGH-RISK INDIVIDUALS (2007) (0)
Abstract 5325: Inherited Human Nox2 Deficiency is Associated With Impaired Isoprostane Formation and Reduced Platelet Recruitment (2009) (0)
T2238C atrial natriuretic peptide gene variant and cardiovascular events in patients with atrial fibrillation: A substudy from the ATHERO-AF cohort. (2020) (0)
373 Decreases of tissue-plasminogen activator inhibitor (PAI) by defibrotide (1988) (0)
Abstract 5090: Nadph Oxidase-mediated Arterial Dysfunction in Patients With Peripheral Arterial Disease (2009) (0)
Measurement of polymorfonuclear leukocytes-derived hydrogen peroxide in whole blood (1993) (0)
Abstract 15810: Pcsk9, Thromboxane and Cardiovacular Events in Atrial Fibrillation (2017) (0)
Response to 'Oxidative stress in patients affected by primary aldosteronism'. (2015) (0)
CAPRIE trial (1997) (0)
Are Antioxidants a Therapeutic Option in COVID-19? (2021) (0)
P2641Circulating lipopolysaccharides and risk of major adverse cardiovascular events in atrial fibrillation: association with mediterranean diet adherence (2017) (0)
Willebrand factor resulting in adhesion of platelets to the site of injury (2013) (0)
heart failure Tumor necrosis factor-alpha as trigger of platelet activation in patients with (2013) (0)
Abstract (2007) (0)
Aldosterone-induced oxidative stress: a potential mechanism of aldosterone autonomy in primary aldosteronism. (2014) (0)
Oxidant Stress in SLE Patients: Relationship to Atherosclerosis (2001) (0)
[3] ADHERENCE TO RESTRICTED-CALORIE, MEDITERRANEAN DIET IMPROVES ENDOTHELIAL DYSFUNCTION AND OXIDATIVE STRESS IN PATIENTS WITH THE METABOLIC SYNDROME (2009) (0)
Abstract 13423: Pm10-Induced Nadph Oxidase Activation: A New Link Between Air Pollution and Oxidative Stress (2011) (0)
[Possible role of serotonin in the etiology of platelet hyperaggregation after bloodletting in patients with chronic respiratory insufficiency]. (1979) (0)
Title Page / Table of Contents / Preface (2003) (0)
Lipoprotein (a) does not influence hyperfibrinolysis in patients with liver cirrhosis (1995) (0)
Correction to: Reduced Lysosomal Acid Lipase Activity in Blood and Platelets Is Associated With Nonalcoholic Fatty Liver Disease. (2020) (0)
Prekallikrein, hageman factor, and high molecular weight kininogen in liver cirrhosis (1986) (0)
Combination of aspirin plus macrolides in patients with severe community-acquired pneumonia: a hypothesis-generating study (2018) (0)
[Use of antithrombotic drugs in the treatment of peripheral occlusive arterial diseases]. (1999) (0)
Relationship between low Ankle-Brachial Index and rapid renal function decline in patients with atrial ﬁ brillation: a prospective multicentre cohort study (2015) (0)
Behaviour of lupus anticoagulant and PAI_1 activity in young patients affected from ischemic stroke (1991) (0)
"Pitfalls in assessing platelet activation status in patients with liver disease: authors' reply". (2012) (0)
[Oxidative stress and hypertension]. (2001) (0)
University of Birmingham Inadequate anticoagulation by Vitamin K Antagonists is associated with Major Adverse Cardiovascular Events in patients with atrial fibrillation (2015) (0)
[Prevention of venous thromboembolism: how important is it in non-surgical disease?]. (2001) (0)
Vitamin e serum levels are associated with cardiovascular events in patients with non-valvular atrial fibrillation (2013) (0)
Abstract 529: Digoxin and Platelet Activation in Atrial fibrillation Patients (2018) (0)
[The role of endogenous hypertriglyceridemia on the behavior of platelet aggregation]. (1978) (0)
Low levels of lipoprotein (A) do not influence hyperfibrinolysis in patients with liver cirrhosis (1994) (0)
University of Urinary 11-dehydro-thromboxane B2 is associated with cardiovascular events and mortality in patients with atrial fibrillation (2015) (0)
Identification of a novel mechanism of human platelet activation dependent on the hydroxyl radicals (1990) (0)
Abstract 15529: Aspirin and Renal Insufficiency Progression in Patients With Atrial Fibrillation and Chronic Kidney Disease (2015) (0)
THU0206 ANTI-D4GDI ANTIB ODIES ACTIVATE PLATELETS IN VITRO: A POSSIBLE LINK WITH THROMBOCYTOPENIA IN PRIMARY ANTIPHOSPHOLIPID SYNDROME (2019) (0)
Reply to Frencken et al. (2017) (0)
PO15-398 OXIDATIVE-STRESS MEDIATED ARTERIAL DYSFUNCTION IN PATIENTS WITH PERIPHERAL ARTERIAL DISEASE (2007) (0)
Vitamin E supplementation [1] (multiple letters) (2001) (0)
[Behavior of the fibrinogen polymerization curve in patients with chronic respiratory insufficiency]. (1983) (0)
Dipyridamole inhibits lipid peroxidation at two different levels: The initiation reaction and the propagation chain reaction (1990) (0)
[Calcium-heparin treatment of chronic disseminated intravascular coagulation in liver cirrhosis]. (1979) (0)
Erratum: (The Journal of Clinical Investigation (October 1997) 100:8 (2028-2034)) (1997) (0)
Endothelial dysfunction and peripheral arterial disease. Authors' reply (2007) (0)
Lysosomal acid lipase activity and liver fibrosis in the clinical continuum of nonalcoholic fatty liver disease (2019) (0)
Leukocyte activation in brain ischemia (1988) (0)
P6228High sensitivity T troponins and risk of mortality and cardiovascular events in patients with community-acquired pneumonia (2017) (0)
TREATMENT WITH ATORVASTATIN AND ALBUMIN INFUSIONS IN A PATIENT WITH CONGENITAL ANALBUMINEMIA (2013) (0)
Fibrin (ogen) polymerization curve (FPC) in patients with "diabetes mellitus". (1981) (0)
Progressive reduction of blood lysosomal acid lipase activity according to stage of adult chronic liver disease and altered enzymatic cellular distribution in cirrhosis (2018) (0)
Oxidative stress and the mechanisms of atherosclerosis (2011) (0)
Aspirin Reload Before Percutaneous Coronary Intervention: Impact on Reperfusion Indexes (2013) (0)
Clotting activation and secondary hyperfibrinolysis in liver cirrhotic patients with ascites (1994) (0)
Response to Duret et al. (2018) (0)
Enhanced monocyte tissue factor expression in patients with type Ha hypercholesterolemia (1996) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Francesco Violi?

Francesco Violi is affiliated with the following schools: